Oxervate .002% ophthalmic solution - pharmacy O
Ended Awarded
- Contract number
- 36C26020F0711
- Awardee
-
Dompe U.s. Inc. UEI ECCDSKQAN2J3
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $70,344
Award facts
- Opportunity
-
- 65IB Drugs, Pharmaceuticals & Hematology Related Products Solicitation Refresh - October 2010 - Version R4 Solicitation · Posted Feb 21, 2014
- Contract value 100% obligated
- $70,344.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Boston, MA 02210, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 to Dompe U.S. Inc. for the provision of OXERVATE 0.002% ophthalmic solution. With a potential value of $70,344.24 and a completion date of October 10, 2020, this firm fixed price contract calls for Dompe U.S. Inc. to deliver the specified pharmaceutical product to locations within Boston, Massachusetts to support the healthcare needs of veterans served by VISN 20. No set-aside designation was applied to this award made under GSA Schedule FSS-61-IB.
Quick answers
Who was awarded contract 36C26020F0711?
36C26020F0711 was awarded to Dompe U.s. Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on September 10, 2020.
How much is contract 36C26020F0711 worth?
The government has obligated $70,344 on 36C26020F0711.
Is contract 36C26020F0711 an order under another contract?
Yes. 36C26020F0711 is a delivery order under 36F79720D0017, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26020F0711 competed?
The extent of competition for 36C26020F0711 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award